Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2011
05/17/2011CA2397194C Alpha v integrin receptor antagonists
05/17/2011CA2197672C Tetrahydrofuran antifungals
05/14/2011CA2739869A1 Radiolabelled inhibitors of the glycine 1 transporter
05/12/2011WO2011057054A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
05/12/2011WO2011055770A1 Fused heterocyclic compound
05/12/2011WO2011055215A2 Novel kinase modulators
05/12/2011WO2011054848A1 Thetrahydroquinolines derivatives as bromodomain inhibitors
05/12/2011WO2010147898A3 Small molecule inhibitors of spleen tyrosine kinase (syk)
05/12/2011WO2010131054A9 Redox drug derivatives
05/12/2011US20110112309 Preparation process useful in synthesis of atorvastatin
05/12/2011US20110112293 Purification Strategy for Direct Nucleophilic Procedures
05/12/2011US20110112154 Compounds, compositions and methods
05/12/2011US20110112146 Chromene modulators of chemokine receptor activity
05/12/2011US20110112145 Salts Of Methyl 2-((R))-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3((R)-tetrahydro-2H-Pyran-3-YL)Propylcarbamoyl)Piperidin-3-YL)Methoxy)Ethylcarbamate
05/12/2011US20110112142 Novel estrogen receptor ligands
05/12/2011US20110112140 Inhibitor of plasminogen activator inhibitor-1
05/12/2011US20110112118 2,4-Diaminoquinazolines for Spinal Muscular Atrophy
05/12/2011US20110112110 Antiproliferative compounds and therapeutic uses thereof
05/12/2011US20110112103 5-hydroxypyrimidine-4-carboxamide compound
05/12/2011US20110112096 Pyrimidine derivatives as kinase inhibitors
05/12/2011US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands
05/12/2011US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods
05/12/2011US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors
05/12/2011US20110112073 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
05/12/2011US20110112071 Novel heterocyclidene acetamide derivative
05/12/2011US20110112066 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
05/12/2011US20110112065 Modulators of dopamine neurotransmission
05/12/2011US20110112063 Pyrimidine derivatives as kinase inhibitors
05/12/2011US20110112060 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
05/12/2011US20110111162 Indolium compound and optical recording material containing the same
05/12/2011US20110111046 N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors
05/12/2011CA2780149A1 Ire-1.alpha. inhibitors
05/12/2011CA2779989A1 Quinazoline compounds
05/12/2011CA2779574A1 Novel kinase modulators
05/12/2011CA2778161A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
05/11/2011EP2319890A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter
05/11/2011EP2319856A1 Methods and compositions for treating hepatitis c virus
05/11/2011EP2319843A1 Substituted pyrrole derivatives and their use as HMG-CO inhibitors
05/11/2011EP2319837A1 Benzimidazole derivatives and their use for modulating the GABAa receptor complex
05/11/2011EP2319831A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent
05/11/2011EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response
05/11/2011EP2318396A1 A crystalline form of posaconazole
05/11/2011EP2318378A2 Quinazoline derivatives
05/11/2011EP2318376A1 Bi-1h-benzimidazoles as hepatitis c virus inhibitors
05/11/2011EP2318374A2 Insecticidal benzenedicarboxamide derivative
05/11/2011EP2134708B1 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
05/11/2011EP2134699B1 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides
05/11/2011EP2042171B1 Therapeutic or prophylactic agent for allergic dermatitis
05/11/2011EP1789036B1 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase
05/11/2011CN102056920A Tetrazole compounds as orexin receptor antagonists
05/11/2011CN102056905A Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
05/11/2011CN102056904A Indane derivatives as AMPA receptor modulators
05/11/2011CN102056903A New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
05/11/2011CN102056894A Homocysteine synthase inhibitor
05/11/2011CN102050817A Synthetic method of N-(4-oxo-6-X-1H-benzofuran-2-tetrazole)-4-phenylbutoxy benzamide
05/11/2011CN102050807A 3-aryl-4-(2-acyloxy ethyoxyl)-2(5H)-furanone compound and preparation method and application thereof
05/11/2011CN102050793A 4(3H) quinazolinone derivatives with antitumor activity
05/11/2011CN102050777A Method for preparing N-substituted-L-methyl tryptophan ester
05/11/2011CN102050758A Novel amide derivatives and medicinal use thereof
05/11/2011CN101072561B Diaminoalkane aspartic protease inhibitors
05/10/2011USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them
05/10/2011US7939685 Hydroxylation of β-dicarbonyls with zirconium catalysts
05/10/2011US7939670 Nociceptin analogs
05/10/2011US7939657 N-substituted benzene sulfonamides
05/10/2011US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
05/10/2011CA2614746C Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
05/10/2011CA2467471C Derivatives of andrimid and moiramide b having antibacterial properties
05/10/2011CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
05/10/2011CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
05/05/2011WO2011053706A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
05/05/2011WO2011051961A1 Compounds for the treatment of dyslipidemia and related diseases
05/05/2011WO2011051853A1 Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren
05/05/2011WO2011051540A1 Androgen receptor modulating compounds
05/05/2011WO2011051478A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
05/05/2011WO2011051242A1 Co-crystal of 4-{[(6-chloropyrid-3-yl)methyl](2,2-difluoroethyl)amino}­furan-2(5h)-one with salicylic acid and use thereof as pesticide
05/05/2011WO2011051241A1 Co-crystal of 4-{[(6-chloropyrid-3-yl)methyl](2,2-difluoroethyl)amino}­furan-2(5h)-one with oxalic acid and use thereof as pesticide
05/05/2011WO2011051240A1 Co-crystal of 4-{[(6-chloropyrid-3-yl)methyl](2,2-difluoroethyl)­amino}­furan-2(5h)-one with benzoic acid and use thereof as a pesticide
05/05/2011WO2011051201A1 Positive allosteric modulators (pam)
05/05/2011WO2011051151A1 Novel solid form of 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5h)-one
05/05/2011WO2011025938A3 Raf inhibitor compounds and methods of use thereof
05/05/2011WO2011006803A9 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition
05/05/2011WO2011006794A9 3-oxo-2, 3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors
05/05/2011WO2010147430A3 Novel c-aryl glucoside sglt2 inhibitors and pharmaceutical composition comprising same
05/05/2011WO2010109185A3 Process for the preparation of doxazosin and salts thereof
05/05/2011US20110105767 Manufacturing process for enantiomerically pure 8-Aryloctanoic acids as Aliskiren
05/05/2011US20110105749 Triazole compounds that modulate hsp90 activity
05/05/2011US20110105747 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
05/05/2011US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof
05/05/2011US20110105567 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity
05/05/2011US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
05/05/2011US20110105533 Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof
05/05/2011US20110105528 1-(7-(hexahydropyrrolo [3, 4-c] pyrrol-2 (1h)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3)
05/05/2011US20110105525 Pharmaceutical compositions containing a crystalline form of posaconazole
05/05/2011US20110105522 Ketoconazole-derivative antagonist of human pregnane x receptor and uses thereof
05/05/2011US20110105513 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
05/05/2011US20110105506 Diaminoalkane aspartic protease inhibitors
05/05/2011US20110105503 Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent
05/05/2011US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors
05/05/2011US20110105475 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
05/05/2011US20110105472 Diaminopyrimidines as crop protection agents